Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study-Reference-Cited by-同舟云学术

Use of simeprevir following pre-emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12-week pilot study

Published:2014-10-22 Issue:2 Volume:22 Page:144-150
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Tanaka Tomohiro¹,Sugawara Yasuhiko²,Akamatsu Nobuhisa²,Kaneko Junichi²,Tamura Sumihito²,Aoki Taku²,Sakamoto Yoshihiro²,Hasegawa Kiyoshi²,Kurosaki Masayuki³,Izumi Namiki³,Kokudo Norihiro²

Affiliation:

1. Organ Transplantation Service; The University of Tokyo Hospital; Tokyo Japan

2. Artificial Organ and Transplantation Division; Department of Surgery; Graduate School of Medicine; The University of Tokyo; 7-3-1 Hongo, Bunkyo-ku Tokyo 113-8655 Japan

3. Division of Gastroenterology and Hepatology; Musashino Red Cross Hospital; Tokyo Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Reference29 articles.

1. The association between hepatitis C infection and survival after orthotopic liver transplantation;Forman;Gastroenterology,2002

2. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients;Berenguer;Hepatology,2002

3. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up;Neumann;Transplantation,2004

4. Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients;Tanaka;Transpl Int,2013

5. Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation;Guillouche;Aliment Pharmacol Ther,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantation;Clinical Journal of Gastroenterology;2018-07-11

2. Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis;Hepatitis Monthly;2017-06-17

3. Asunaprevir/daclatasvir and sofosbuvir/ledipasvir for recurrent hepatitis C following living donor liver transplantation;Hepatology Research;2016-12-15

4. Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C;British Journal of Clinical Pharmacology;2016-10-26

5. Efficacy and Tolerability of Pegylated Interferon and Ribavirin in Combination with Simeprevir to Treat Hepatitis C Virus Infections After Living Donor Liver Transplantation;Journal of Interferon & Cytokine Research;2016-06